Brief report: weight gain in persons with HIV switched from efavirenz-based to integrase strand transfer inhibitor–based regimens

J Norwood, M Turner, C Bofill, P Rebeiro… - JAIDS Journal of …, 2017 - journals.lww.com
Background: With the introduction of integrase strand transfer inhibitor (INSTI)-based
antiretroviral therapy, persons living with HIV have a potent new treatment option. Recently …
被引用次数：303 相关文章
[PDF] natap.org

[PDF][PDF] Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor–Based Regimens

J Norwood, M Turner, C Bofill, P Rebeiro… - J Acquir Immune Defic …, 2017 - natap.org
Background: With the introduction of integrase strand transfer inhibitor (INSTI)-based
antiretroviral therapy, persons living with HIV have a potent new treatment option. Recently …
[PDF] natap.org

[PDF][PDF] Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor–Based Regimens

J Norwood, M Turner, C Bofill, P Rebeiro… - J Acquir Immune Defic …, 2017 - natap.org
Background: With the introduction of integrase strand transfer inhibitor (INSTI)-based
antiretroviral therapy, persons living with HIV have a potent new treatment option. Recently …

Brief Report: Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor-Based Regimens.

J Norwood, M Turner, C Bofill, P Rebeiro… - Journal of Acquired …, 2017 - europepmc.org
Background With the introduction of integrase strand transfer inhibitor (INSTI)-based
antiretroviral therapy, persons living with HIV have a potent new treatment option. Recently …
[HTML] nih.gov

[HTML][HTML] Weight Gain in Persons with HIV Switched from Efavirenz-based to Integrase Strand Transfer Inhibitor-based Regimens

J Norwood, M Turner, C Bofill, P Rebeiro… - Journal of acquired …, 2017 - ncbi.nlm.nih.gov
Background With the introduction of integrase strand transfer inhibitor (INSTI)-based
antiretroviral therapy (ART), persons living with HIV have a potent new treatment option …
[PDF] academia.edu

[PDF][PDF] Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor–Based Regimens

J Norwood, M Turner, C Bofill, P Rebeiro… - J Acquir Immune Defic …, 2017 - academia.edu
Background: With the introduction of integrase strand transfer inhibitor (INSTI)-based
antiretroviral therapy, persons living with HIV have a potent new treatment option. Recently …

Brief report: weight gain in persons with HIV switched from efavirenz-based to integrase strand transfer inhibitor-based regimens.

J Norwood, M Turner, C Bofill, P Rebeiro, B Shepherd… - 2017 - cabidigitallibrary.org
Background: With the introduction of integrase strand transfer inhibitor (INSTI)-based
antiretroviral therapy, persons living with HIV have a potent new treatment option. Recently …

Brief Report: Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor-Based Regimens

J Norwood, M Turner, C Bofill… - Journal of acquired …, 2017 - pubmed.ncbi.nlm.nih.gov
Background With the introduction of integrase strand transfer inhibitor (INSTI)-based
antiretroviral therapy, persons living with HIV have a potent new treatment option. Recently …

Brief Report: Weight Gain in Persons With HIV Switched From Efavirenz-Based to Integrase Strand Transfer Inhibitor–Based Regimens

J Norwood, M Turner, C Bofill, P Rebeiro… - JAIDS Journal of …, 2017 - cir.nii.ac.jp
抄録< jats: sec>< jats: title> Background:</jats: title>< jats: p> With the introduction of
integrase strand transfer inhibitor (INSTI)-based antiretroviral therapy, persons living with …